Trials / Completed
CompletedNCT06211829
An Evaluation of a Antimicrobial Stewardship Recommendation Bundle for Staphylococcus Aureus Bloodstream Infections
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 77 (actual)
- Sponsor
- Methodist Health System · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- —
Summary
In July 2020, a bundle (Appendix C) was implemented at Methodist Dallas Medical Center where all patients with SAB were reviewed by the antimicrobial stewardship pharmacist (Monday - Friday from 0700 to 1500), a note outlining optimal interventions was written in the electronic medical record (EMR), and the recommendations were communicated to the primary team via secure messaging or telephone
Detailed description
Evaluation of the Staphylococcus aureus bloodstream infection(SAB)bundle recommendations will allow for determination of whether this intervention is impactful and warrants the resources currently devoted to it.
Conditions
Timeline
- Start date
- 2022-05-18
- Primary completion
- 2025-07-14
- Completion
- 2025-07-14
- First posted
- 2024-01-18
- Last updated
- 2025-08-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06211829. Inclusion in this directory is not an endorsement.